lysine has been researched along with AIDS Seroconversion in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Eren, E; Huang, PL; Lee-Huang, S; Palmer, I; Shoemaker, RH; Watts, NR; Wingfield, PT | 1 |
Jia, X; Jiang, X; Lu, L; Qi, C; Sun, J; Wang, Y; Wei, M; Zhang, L | 1 |
Gordon, M; Hampton, J; Johnson, B; Kuritzkes, DR; Marconi, VC; Moosa, MY; Ordonez, C; Sunpath, H; Wu, B | 1 |
Arribas, JR; Bernardino, JI; Estebanez, M; García-Bujalance, S; Martin-Quirós, A; Mingorance, J; Pérez-Valero, I; Ruiz-Carrascoso, G; Stella-Ascariz, N; Zamora, FX | 1 |
Chiang, CF; Garry, RF; Leissinger, CA; Tenenbaum, SA; Verret, CR | 1 |
Benner, A; Breitkreutz, R; Dröge, W; Holm, E; Pittack, N; Rossol, S; Stein, J; Tokus, M; Wagner, J | 1 |
6 other study(ies) available for lysine and AIDS Seroconversion
Article | Year |
---|---|
The ribosome-inactivating proteins MAP30 and Momordin inhibit SARS-CoV-2.
Topics: Alanine; COVID-19; COVID-19 Drug Treatment; HIV Seropositivity; HIV-1; Humans; Lysine; Momordica charantia; Ribosome Inactivating Proteins; Ribosomes; SARS-CoV-2 | 2023 |
Overexpressed coiled-coil domain containing protein 8 (CCDC8) mediates newly synthesized HIV-1 Gag lysosomal degradation.
Topics: Carrier Proteins; CD4-Positive T-Lymphocytes; Cell Membrane; Endocytosis; Endoplasmic Reticulum; gag Gene Products, Human Immunodeficiency Virus; Green Fluorescent Proteins; HEK293 Cells; HIV Seropositivity; HIV-1; Humans; Lysine; Lysosomes; Phylogeny; Protein Processing, Post-Translational; Virion; Virus Assembly | 2020 |
High rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimen.
Topics: Adenine; Adult; Arginine; CD4 Lymphocyte Count; Cohort Studies; Drug Resistance, Viral; Female; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Lamivudine; Lysine; Male; Mutation; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; South Africa; Stavudine; Tenofovir; Treatment Failure; Viral Load | 2012 |
Is etravirine and two nucleosides an option for HIV with an isolated K103N mutation?
Topics: Adenine; Adult; Anti-HIV Agents; Asparagine; Deoxycytidine; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Emtricitabine; Female; Genotype; HIV Seropositivity; HIV-1; Humans; Lysine; Male; Mutation; Nitriles; Organophosphonates; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; Tenofovir | 2013 |
Activity of granzyme A, a serine protease in the killing granules of cytotoxic T lymphocytes, is reduced in cells from HIV-infected hemophiliacs.
Topics: Cohort Studies; Female; Granzymes; Hemophilia A; Hemophilia B; HIV Seronegativity; HIV Seropositivity; Humans; Lysine; Male; Serine Endopeptidases; T-Lymphocytes, Cytotoxic | 1996 |
Flux of amino acids and energy substrates across the leg in weight-stable HIV-infected patients with acute opportunistic infections: indication of a slow protein wasting process.
Topics: Adult; AIDS-Related Opportunistic Infections; Amino Acids; Arginine; Blood Glucose; Case-Control Studies; Dose-Response Relationship, Drug; Erythrocytes; Fatty Acids; Female; Glycerol; HIV Seropositivity; HIV Wasting Syndrome; Humans; Insulin; Interleukin-6; Ketones; Lactic Acid; Leg; Lysine; Male; Middle Aged; Muscle, Skeletal; Nitrogen; Pyruvic Acid | 2001 |